GLP1-RA Add-on Therapy in Patients with Type 2 Diabetes Currently on a Bolus Containing Insulin Regimen-Reference-Cited by-同舟云学术

GLP1-RA Add-on Therapy in Patients with Type 2 Diabetes Currently on a Bolus Containing Insulin Regimen

Published:2016-08 Issue:8 Volume:36 Page:893-905
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Davies Marie L.¹²,Pham David Q.¹³,Drab Scott R.⁴⁵

Affiliation:

1. Department of Pharmacy Practice and Administration; Western University of Health Sciences College of Pharmacy; Pomona California

2. Harbor UCLA Family Health Center; Harbor City California

3. Mary & Dick Allen Diabetes Center; Newport Beach California

4. Department of Pharmacy & Therapeutics; University of Pittsburgh School of Pharmacy; Pittsburgh Pennsylvania

5. University Diabetes Care Associates; Greensburg Pennsylvania

Publisher

Wiley

Subject

Pharmacology (medical)

Reference38 articles.

2. Standards of Medical Care in Diabetes - 2016;American Diabetes Association;Diabetes Care,2016

3. Prescribing information. Byetta (exenatide) San Diego, CA Amylin Pharmaceuticals, Inc.

4. Prescribing information. Victoza (liraglutidine) Bagsvaerd, Denmark Novo Nordisk

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献